首页> 外国专利> USE OF HLA-A*11:01-RESTRICTED HEPATITIS B VIRUS (HBV) PEPTIDES FOR IDENTIFYING HBV-SPECIFIC CD8+ T CELLS

USE OF HLA-A*11:01-RESTRICTED HEPATITIS B VIRUS (HBV) PEPTIDES FOR IDENTIFYING HBV-SPECIFIC CD8+ T CELLS

机译:使用HLA-A * 11:01限制的乙型肝炎病毒(HBV)肽鉴定HBV特异性CD8 + T细胞

摘要

The present invention relates to peptides and their ability to identify and bind to T cells specific for HBV-infected hepatocytes. In an first aspect of the invention, there is provided a peptide comprising an amino sequence selected from the group consisting of STLPETAVVRR, STLPETAVVR, STLPETTVVRR, STLPETTVIRR, STPPETTVVRR, STLPETTVVGR and STIPETTVVRR, wherein the peptide is derived from Hepatitis B virus core169 and is capable of binding HLA-A*1101 and when bound to HLA-A*1101 is capable of identifying T cells specific for Hepatitis B virus. In a second aspect of the invention, there is provided A T cell expressing a T cell receptor (TCR) molecule, wherein the TCR molecule comprises an amino acid sequence selected from the group comprising: CASGDSNSPLHF, CASSGGQIVYEQYF, CSARGGRGGDYTF and CASSQDWTEAFF, the T cell receptor is able to bind to a peptide according to the first aspect of the invention.
机译:本发明涉及肽及其鉴定和结合对HBV感染的肝细胞特异的T细胞的能力。在本发明的第一方面,提供了一种肽,其包含选自以下的氨基序列:STLPETAVVRR,STLPETAVVR,STLPETTVVRR,STLPETTVIRR,STPPETTVVRR,STLPETTVVGR和STIPETTVVRR,其中该肽衍生自乙型肝炎病毒核心169并且能够结合HLA-A * 1101的能力,并且当与HLA-A * 1101结合时能够鉴定对乙型肝炎病毒特异的T细胞。在本发明的第二方面,提供了表达T细胞受体(TCR)分子的AT细胞,其中TCR分子包含选自以下的氨基酸序列:CASGDSNSPLHF,CASSGGQIVYEQYF,CSARGGRGGDYTF和CASSQDWTEAFF,T细胞受体能够结合根据本发明的第一方面的肽。

著录项

  • 公开/公告号WO2020145901A1

    专利类型

  • 公开/公告日2020-07-16

    原文格式PDF

  • 申请/专利权人 AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH;

    申请/专利号WO2020SG50017

  • 发明设计人 CHENG YANG;NEWELL EVAN;

    申请日2020-01-13

  • 分类号C07K7/06;C12N5/0783;A61K39/29;A61K35/12;A61P31/20;

  • 国家 WO

  • 入库时间 2022-08-21 11:10:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号